InsiderTrades

Form 4 for SI SHOULDER INNOVATIONS, INC.

Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0002070664-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-10 2026-02-06 SI Ball Robert Joseph CEO, Executive COB, Dir M - OptEx $2.42 +12.1K 274.6K +5% +$29.1K
DM 2026-02-10 2026-02-06 SI Ball Robert Joseph CEO, Executive COB, Dir M - OptEx $0.00 -12.1K 319.8K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-06 M A 2,062 $2.10 276,666 D — —
2 Common Common Stock 2026-02-06 M A 10,000 $2.48 274,604 D — — (F1) Includes the following shares received without consideration as in-kind distributions: (i) 110,331 shares from Genesis Investment Holdings; (ii) 7,859 shares from cultivate(MD) Capital Accelerator Fund, L.P.; (iii) 6,948 shares from Cultivate MD Capital Fund I, LLC; and (iv) 19,348 shares from Cultivate MD Capital Fund II, LP. In prior reports, the reporting person reported beneficial ownership of 120,118 shares of Shoulder Innovations common stock held directly.
3 Derivative Stock Option 2026-02-06 M D 2,062 $0.00 181,376 D $2.10 · — to 2030-12-16 2,062 Common Stock (F3) The stock option is fully vested and currently exercisable.
4 Derivative Stock Option 2026-02-06 M D 10,000 $0.00 319,756 D $2.48 · — to 2033-05-17 10,000 Common Stock (F2) The stock option vested as to one-fourth of the underlying shares on May 17, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter.